Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation. - Trial NCT06259084
Access comprehensive clinical trial information for NCT06259084 through Pure Global AI's free database. This phase not specified trial is sponsored by Manina Medtech and is currently Not yet recruiting. The study focuses on Infertility. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Manina Medtech
Timeline & Enrollment
N/A
Feb 05, 2024
Apr 05, 2025
Primary Outcome
Intrauterine biomarker concentration on the day before embryo transfer,Intrauterine biomarker concentration on the embryo transfer day
Summary
In Vitro Fertilization (IVF) success is below 40%, with Embryo Transfer the leading cause of
 IVF failure. This clinical investigation aims to evaluate if the levels of an intrauterine
 biomarker dissolved in the uterine fluid (alone or as a complex biological marker) can
 predict the outcome of embryo transfer.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06259084
Device Trial